Insulin Resistance in NSCLC: Unraveling the Link Between Development, Diagnosis, and Treatment

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Mar 7

PMID 38449844

Authors

Shizhang Zhan

Liu Wang

Wenping Wang

Ruoran Li

Affiliations

Soon will be listed here.

Abstract

Lung cancer is responsible for the highest number of cancer-related deaths, with non-small cell lung cancer (NSCLC) being the most prevalent subtype. A critical aspect of managing lung cancer is reducing morbidity and mortality rates among NSCLC patients. Identifying high-risk factors for lung cancer and facilitating early diagnosis are invaluable in achieving this objective. Recent research has highlighted the association between insulin resistance and the development of NSCLC, further emphasizing its significance in the context of lung cancer. It has been discovered that improving insulin resistance can potentially inhibit the progression of lung cancer. Consequently, this paper aims to delve into the occurrence of insulin resistance, the mechanisms underlying its involvement in lung cancer development, as well as its potential value in predicting, assessing, and treating lung cancer.

Citing Articles

Causal relationship between diabetes mellitus and lung cancer: a two-sample Mendelian randomization and mediation analysis.

Yu X, Fu B, Sun T, Sun X Front Genet. 2024; 15:1449881.

PMID: 39655224 PMC: 11625780. DOI: 10.3389/fgene.2024.1449881.

[Progress in the Study of Mechanisms Clinically Relevant to Insulin Resistance  and Lung Cancer].

Chen X, Chen P Zhongguo Fei Ai Za Zhi. 2024; 27(10):755-762.

PMID: 39631832 PMC: 11629090. DOI: 10.3779/j.issn.1009-3419.2024.106.27.

References

Li Z, Zhang H . Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci. 2015; 73(2):377-92. PMC: 11108301. DOI: 10.1007/s00018-015-2070-4. View

Randle P, Garland P, Hales C, Newsholme E . The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963; 1(7285):785-9. DOI: 10.1016/s0140-6736(63)91500-9. View

Yu J, Zhang L, Peng J, Ward R, Hao P, Wang J . Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways. Biochem Pharmacol. 2021; 195:114864. DOI: 10.1016/j.bcp.2021.114864. View

Semple R, Sleigh A, Murgatroyd P, Adams C, Bluck L, Jackson S . Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest. 2009; 119(2):315-22. PMC: 2631303. DOI: 10.1172/JCI37432. View

ArulJothi K, Kumaran K, Senthil S, Nidhu A, Munaff N, Janitri V . Implications of reactive oxygen species in lung cancer and exploiting it for therapeutic interventions. Med Oncol. 2022; 40(1):43. PMC: 9734980. DOI: 10.1007/s12032-022-01900-y. View

Fumarola C, Bonelli M, Petronini P, Alfieri R . Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer. Biochem Pharmacol. 2014; 90(3):197-207. DOI: 10.1016/j.bcp.2014.05.011. View

Boucher J, Tseng Y, Kahn C . Insulin and insulin-like growth factor-1 receptors act as ligand-specific amplitude modulators of a common pathway regulating gene transcription. J Biol Chem. 2010; 285(22):17235-45. PMC: 2878077. DOI: 10.1074/jbc.M110.118620. View

Bonora E, Targher G, Alberiche M, Bonadonna R, Saggiani F, Zenere M . Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000; 23(1):57-63. DOI: 10.2337/diacare.23.1.57. View

Xu X, Qiu Y, Chen S, Wang S, Yang R, Liu B . Different Roles of the Insulin-like Growth Factor (IGF) Axis in Non-small Cell Lung Cancer. Curr Pharm Des. 2022; 28(25):2052-2064. DOI: 10.2174/1381612828666220608122934. View

10.

Samuel V, Shulman G . Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases. Cell Metab. 2017; 27(1):22-41. PMC: 5762395. DOI: 10.1016/j.cmet.2017.08.002. View

11.

Hosoe J, Kadowaki H, Miya F, Aizu K, Kawamura T, Miyata I . Structural Basis and Genotype-Phenotype Correlations of INSR Mutations Causing Severe Insulin Resistance. Diabetes. 2017; 66(10):2713-2723. DOI: 10.2337/db17-0301. View

12.

Dali-Youcef N, Hnia K, Blaise S, Messaddeq N, Blanc S, Postic C . Matrix metalloproteinase 11 protects from diabesity and promotes metabolic switch. Sci Rep. 2016; 6:25140. PMC: 4850390. DOI: 10.1038/srep25140. View

13.

LeRoith D, Yakar S . Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab. 2007; 3(3):302-10. DOI: 10.1038/ncpendmet0427. View

14.

Cai H, Sobue T, Kitamura T, Ishihara J, Murai U, Sawada N . Dietary fibre intake is associated with reduced risk of lung cancer: a Japan public health centre-based prospective study (JPHC). Int J Epidemiol. 2022; 51(4):1142-1152. DOI: 10.1093/ije/dyac054. View

15.

Petersen M, Shulman G . Mechanisms of Insulin Action and Insulin Resistance. Physiol Rev. 2018; 98(4):2133-2223. PMC: 6170977. DOI: 10.1152/physrev.00063.2017. View

16.

Al-Saad S, Richardsen E, Kilvaer T, Donnem T, Andersen S, Khanehkenari M . The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer. PLoS One. 2017; 12(7):e0181527. PMC: 5526580. DOI: 10.1371/journal.pone.0181527. View

17.

Flier J . Insulin receptors and insulin resistance. Annu Rev Med. 1983; 34:145-60. DOI: 10.1146/annurev.me.34.020183.001045. View

18.

Tian Z, Yao G, Song H, Zhou Y, Geng J . IGF2R expression is associated with the chemotherapy response and prognosis of patients with advanced NSCLC. Cell Physiol Biochem. 2014; 34(5):1578-88. DOI: 10.1159/000366361. View

19.

Djiogue S, Nwabo Kamdje A, Vecchio L, Kipanyula M, Farahna M, Aldebasi Y . Insulin resistance and cancer: the role of insulin and IGFs. Endocr Relat Cancer. 2012; 20(1):R1-R17. DOI: 10.1530/ERC-12-0324. View

20.

Perry R, Camporez J, Kursawe R, Titchenell P, Zhang D, Perry C . Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell. 2015; 160(4):745-758. PMC: 4498261. DOI: 10.1016/j.cell.2015.01.012. View